This trial will study the effects of radiation on the immune system in patients with early stage lung cancer who are surgical candidates. Tumor, normal tissue and blood specimens will be analyzed for changes in the immune system.
- Non-Small Cell Lung Cancer
1 Primary · 5 Secondary · Reporting Duration: through study completion, an average of 18 months
Awards & Highlights
1 Treatment Group
1 of 1
10 Total Participants · 1 Treatment Group
Primary Treatment: Non-ablative SBRT · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What is the participant capacity for this research project?
"Affirmative. According to clinicaltrials.gov, an up-to-date record of this medical trial is being kept and the recruitment process has commenced since October 1st 2021. The research requires 10 individuals from a single study site to be enrolled in total." - Anonymous Online Contributor
Are there vacancies for participants in this investigation?
"Affirmative. Clinicaltrials.gov denotes that this medical research is actively searching for participants, having been first posted on October 1st 2021 and recently updated on March 21st 2022. At present, 10 individuals need to be enrolled from one specific site." - Anonymous Online Contributor